| (AUD) | Dec 2013 | Y/Y change |
|---|---|---|
| Revenue | 2.16M | -55.82% |
| Operating expense | — | — |
| Net income | -12.67M | 14.64% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AVE.AX returned +192.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +111.1% |
| 1 year | +192.3% |
| 5 years | +18.7% |
| 10 years | +2.4% |
| All-time high | $1.30 (Jan 1996) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AVE.AX would be worth today ›No. Avecho Biotechnology Limited has not paid a dividend in the past 12 months.
Avecho Biotechnology Limited is part of the Healthcare sector.
Avecho Biotechnology Limited has a market cap of 73.41M AUD, based on the latest quote.
